Fibroblast growth factor 23 in patients undergoing peritoneal dialysis - Wikidata - wikimedia - TriplyDB

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

http://www.wikidata.org/entity/Q35499669

about

Fibroblast growth factor 23 Calcium and phosphate impact cardiovascular risk.The use of fibroblast growth factor 23 testing in patients with kidney disease.Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis.Urine fibroblast growth factor 23 levels in hypertensive children and adolescents.Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.FGF-23 levels in patients with AKI and risk of adverse outcomes.Update on fibroblast growth factor 23 in chronic kidney disease.Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.Renal Clearance of Mineral Metabolism Biomarkers Associations of fibroblast growth factor 23 with parameters of phosphate metabolism in incident peritoneal dialysis patients.Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.Plasma FGF23 levels increase rapidly after acute kidney injury.Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients.FGF23 and mineral metabolism in the early post-renal transplantation period.Effect of Mineral and Bone Metabolism on Restless Legs Syndrome in Hemodialysis Patients.Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis.Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.Should monitoring of fibroblast growth factor-23 levels in dialysis patients be a part of routine clinical practice?Prognostic value of FGF23 among patients with end-stage renal disease: a systematic review and meta-analysis.Hemodialysis is associated with higher serum FGF23 level when compared with peritoneal dialysis.Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.Effects of klotho deletion from bone during chronic kidney disease.Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells.Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients.Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.FGF23 beyond mineral metabolism: a bridge to cardiovascular disease.Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patients.Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.Total Phosphate Elimination is Negatively Associated With Increased Serum Fibroblast Growth Factor 23 Levels in Patients who Undergo Peritoneal Dialysis.Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?Fibroblast growth factor-23 levels are associated with vascular calcifications in peritoneal dialysis patients.Phosphate control in reducing FGF23 levels in hemodialysis patients

P2860

Q26829294-80489E62-2D53-4DF3-82B9-C1DB4BEE5212 Q27687570-FBF793C0-F853-443D-9D3A-E2F90281E60B Q33835743-DD4DAA42-6666-4262-8C35-A36A70D2E8EE Q35067500-E8211AE6-5120-42B6-AA17-C7E6F708C034 Q35232118-56952C24-71FB-4E9D-9B5C-62A037544AA5 Q36077946-6FA69136-A454-41BE-B4E4-47A066685847 Q36104887-9F06E9BD-423B-449B-9091-A73AEF91E211 Q36126891-72A13B69-8391-4625-91B7-347EDC74D139 Q36210285-7AB87456-332A-4B6A-BCF1-601A2036CA2A Q36476324-D4DE2C10-4B15-4CA0-B509-7E675B7492FB Q36514947-2D61B422-2E16-48F6-B6FA-D4593B4638A8 Q37000712-0E7436AA-7F7F-48CA-BE37-7C0831CB0B7E Q37126261-5AE5D2C9-A32D-4C4D-95A0-5C8879F66DE9 Q37154351-8A793459-FBC0-4A67-939A-E97D3EAF462F Q37212400-EF07B6B4-A058-4349-818F-48E00D5CB1AE Q37228152-F6B28A5D-24AB-42C2-BB24-202070DB3B3F Q37530199-00CD9688-4C85-435D-AF14-AE637EAA1AAF Q37542837-8C2EEFE0-FE8D-4F39-9C98-0F9CECAE7256 Q38034690-E00DD2C0-087B-4F97-96A2-CF512210C802 Q38231420-5B15D2CC-ED6D-4A2F-BD06-F875BD9A6419 Q38807804-0C7E9ECA-E437-43B7-8C7E-C9D47B82F6A7 Q38813342-30628798-7F99-4F6B-B529-5272761D0B36 Q39056902-BBFCBCAD-815A-47F3-B4F4-414B835CFED1 Q39148454-9D72950D-846F-4ABC-B6C0-57AA7CFBE441 Q39569165-D87878AC-5B39-4D14-905A-1661E1E1CBC4 Q39973995-E8B19B01-035A-4FEC-88DD-3D98D39E26C8 Q40279706-A4FC6327-FBE9-4025-BCB6-A8F1A4BF96BE Q42951465-B40DE2FA-0D94-4EEF-B544-1F3869D709DD Q44410394-8E9E07E0-8BDE-4C36-850B-3BD66438F7E8 Q46419301-47E4EC91-81FF-4B96-B28C-C74EDD23B719 Q51197552-C5C758E7-3AD7-42F2-8F95-E57D36E57022 Q52894312-7BE045E8-A9FC-45D0-91EB-2F38FFF43334 Q53342879-B21B7308-C369-4BBE-BDE7-D3CC82F5EAA2 Q54700038-5FF8D411-FBFE-4091-8BC4-EEAACE5314E7 Q58797979-D1FF0553-033A-4312-AE8D-D7E614ED29C5

P2860

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

http://www.wikidata.org/entity/Q35499669

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

@ast

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

@en

type

label

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

@ast

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

@en

prefLabel

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

@ast

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

@en

P1433

Q35499669-BBEEA3CE-7726-4DBC-B79C-5A183B85ECCA

P1476

Q35499669-8E816C27-6C64-44D1-B29B-49BDC0350B95

P2093

Q35499669-001BFC76-D91F-44E2-9D83-650CBCDB1A61

Q35499669-02E6165C-162B-458D-8BAF-9C59F74BB3E4

Q35499669-0B8B8DE0-B695-4DA6-BA3E-7A2AFD420173

Q35499669-0FEBFD6A-92AA-44B2-B441-EFA0BED6DC32

Q35499669-204571F4-E46D-4E1C-BC26-20574D20E1D6

Q35499669-3047E45C-C6DD-452A-B95C-2C4258F221D6

Q35499669-5A7E490D-DDA7-4CFA-B7A6-D800001F2A7A

Q35499669-72337E2F-ACAD-45D8-99AD-AB2712ED9787

Q35499669-7AFEFF7E-55C7-427E-8F48-FC9B02E3D6E6

Q35499669-92DBF174-251D-4848-871F-5996947AFE36

P2860

Q35499669-020C0563-486A-450D-8B89-13C0FB1C5264

Q35499669-1266CE96-67FC-4A29-919E-1F9D7133B123

Q35499669-2EA581D3-8303-4296-8F98-523511FAE44A

Q35499669-3683F609-BD05-4DDD-924B-6B2A55272786

Q35499669-3DC247AF-55A9-47C4-974D-C824920330F1

Q35499669-46132D76-05AB-4A7A-8DA6-F5EE0245363C

Q35499669-4BE71702-B36C-4871-AD3A-2460AFBD59E6

Q35499669-5004CDC8-FD18-4F8C-BFF0-2CB0B70D559A

Q35499669-551FA856-1BA2-4796-B17C-4B9F07AF6E25

Q35499669-666E44BF-221E-4206-9374-1EF61A41251B

P304

Q35499669-1DED856F-BD8E-49CD-9029-DFE2BEDC9F43

P31

Q35499669-51EFB778-AF04-4303-90B3-400A98FE985C

P356

Q35499669-92CAE419-F4BB-4A72-84FA-BFF231554174

P433

Q35499669-FD9D1C68-F53A-4151-8D9A-9181FE5F4E8A

P478

Q35499669-E788CB16-7C4C-49E9-82C5-6277DDC06645

P50

Q35499669-4D48A44D-442A-4750-B242-8D1F3F564589

P577

Q35499669-87B41D81-6951-4796-9109-6051833A5FC8

P698

Q35499669-32BE4755-35D3-4E38-A7D6-F359C352E9C9

P921

Q35499669-E98E6997-3EF0-48F5-97E4-F884E89A3A80

P932

Q35499669-885E5D94-7E12-45C3-8CA1-4722B4B4B319

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

@en

P2093

Allison Barchi-Chung

http://www.w3.org/2001/XMLSchema#string

Andrew Lundquist

http://www.w3.org/2001/XMLSchema#string

Gabriel Contreras

http://www.w3.org/2001/XMLSchema#string

Gabriela Vargas

http://www.w3.org/2001/XMLSchema#string

Harald Jueppner

http://www.w3.org/2001/XMLSchema#string

Huiliang Xie

http://www.w3.org/2001/XMLSchema#string

Jessica Houston

http://www.w3.org/2001/XMLSchema#string

Kelsey Smith

http://www.w3.org/2001/XMLSchema#string

Luis Ortega

http://www.w3.org/2001/XMLSchema#string

Michael Epstein

http://www.w3.org/2001/XMLSchema#string

P2860

The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.

Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults.

The emerging role of phosphate in vascular calcification.

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis.

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

P304

2688-2695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.04290511

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21903990

http://www.w3.org/2001/XMLSchema#string

P921

P932

3206004

http://www.w3.org/2001/XMLSchema#string